Ending the pharmacogenomic gag rule: the imperative to report all results
Pharmacogenomics
.
2021 Mar;22(4):191-193.
doi: 10.2217/pgs-2020-0172.
Epub 2021 Feb 24.
Authors
Colin Me Halverson
1
2
,
Victoria M Pratt
3
,
Todd C Skaar
4
,
Peter H Schwartz
1
2
Affiliations
1
Center for Bioethics, Indiana University, Indianapolis, IN 46202, USA.
2
Department of Medicine, Division of General Internal Medicine & Geriatrics, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
3
Department of Medical & Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
4
Department of Medicine, Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
PMID:
33622053
DOI:
10.2217/pgs-2020-0172
No abstract available
Keywords:
bioethics; insurance; pharmacogenomics.
Publication types
Editorial
MeSH terms
Adverse Drug Reaction Reporting Systems
Humans
Negative Results
Pharmacogenetics / ethics*
Pharmacogenomic Testing
Precision Medicine
Publishing